DONEPEZIL HYDROCHLORIDE

DONEPEZIL HYDROCHLORIDE was reported 37098 times

DONEPEZIL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROGLYCOPENIA 31 0.2818
1 AMAUROSIS FUGAX 235 0.2182
2 SUPERFICIAL SIDEROSIS OF CENTRAL NERVOUS SYSTEM 25 0.1969
3 PLEUROTHOTONUS 132 0.1460
4 CHOLINERGIC SYNDROME 92 0.1442
5 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 146 0.1361
6 PORIOMANIA 23 0.1204
7 DEMENTIA ALZHEIMER'S TYPE 147 0.0880
8 DEMENTIA WITH LEWY BODIES 92 0.0827
9 MULTIPLE DRUG THERAPY 61 0.0809
10 PERIPHERAL CIRCULATORY FAILURE 33 0.0805
11 DROPPED HEAD SYNDROME 29 0.0734
12 ANTICHOLINERGIC SYNDROME 105 0.0659
13 VASCULAR DEMENTIA 54 0.0616
14 NEURODEGENERATIVE DISORDER 37 0.0600
15 SEXUALLY INAPPROPRIATE BEHAVIOUR 26 0.0558
16 DIABETIC HYPEROSMOLAR COMA 23 0.0532
17 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 21 0.0522
18 SICK SINUS SYNDROME 58 0.0504
19 URINARY TRACT DISORDER 214 0.0475
20 HAEMORRHAGIC STROKE 318 0.0407
21 REDUCED FACIAL EXPRESSION 41 0.0404
22 DEMENTIA 1120 0.0400
23 ELECTROCARDIOGRAM PR PROLONGATION 30 0.0392
24 SINUS NODE DYSFUNCTION 60 0.0327
25 DELUSION 488 0.0314
26 ATRIOVENTRICULAR BLOCK FIRST DEGREE 136 0.0313
27 BRADYARRHYTHMIA 50 0.0304
28 SINUS BRADYCARDIA 257 0.0266
29 CEREBRAL ATROPHY 95 0.0238
30 HYPERSEXUALITY 41 0.0224
31 STOMA SITE DISCHARGE 61 0.0223
32 OCULAR DISCOMFORT 247 0.0220
33 PARKINSONISM 214 0.0219
34 SEDATION COMPLICATION 55 0.0215
35 HALLUCINATION 1605 0.0213
36 LIBIDO INCREASED 43 0.0212
37 ALTERED STATE OF CONSCIOUSNESS 457 0.0211
38 CHOREA 36 0.0209
39 STOMA SITE HAEMORRHAGE 32 0.0208
40 HALLUCINATION, VISUAL 432 0.0204
41 ATRIAL TACHYCARDIA 42 0.0200
42 POSTURE ABNORMAL 64 0.0197
43 BRADYKINESIA 116 0.0196
44 FEMORAL NECK FRACTURE 100 0.0195
45 LABELLED DRUG-DRUG INTERACTION ISSUE 28 0.0193
46 TORTICOLLIS 41 0.0193
47 NEUROLEPTIC MALIGNANT SYNDROME 229 0.0193
48 BRADYCARDIA 1016 0.0191
49 SINUS ARREST 30 0.0191
50 GENERALISED OEDEMA 233 0.0188
51 HYPORESPONSIVE TO STIMULI 22 0.0187
52 HALLUCINATIONS, MIXED 78 0.0185
53 PARKINSON'S DISEASE 47 0.0185
54 NONSPECIFIC REACTION 101 0.0184
55 STUPOR 59 0.0183
56 MUSCLE RIGIDITY 216 0.0180
57 STOMA SITE INFECTION 23 0.0177
58 STOMA SITE PAIN 25 0.0170
59 FREEZING PHENOMENON 63 0.0170
60 ESSENTIAL HYPERTENSION 31 0.0169
61 DROOLING 114 0.0165
62 SLOW SPEECH 40 0.0165
63 GASTRIC POLYPS 37 0.0164
64 HEAD DISCOMFORT 289 0.0163
65 TORSADE DE POINTES 128 0.0163
66 SIALOADENITIS 22 0.0161
67 BLOOD CHOLESTEROL DECREASED 30 0.0161
68 SLEEP TALKING 27 0.0159
69 ATRIOVENTRICULAR BLOCK COMPLETE 106 0.0158
70 DELIRIUM 542 0.0156
71 IMMOBILE 67 0.0153
72 ATRIOVENTRICULAR BLOCK SECOND DEGREE 46 0.0151
73 LONG QT SYNDROME 36 0.0150
74 COMMUNICATION DISORDER 57 0.0149
75 INCONTINENCE 153 0.0145
76 LIVING IN RESIDENTIAL INSTITUTION 27 0.0144
77 HAEMATEMESIS 361 0.0142
78 ANAL INCONTINENCE 128 0.0142
79 ORTHOSTATIC HYPOTENSION 246 0.0141
80 HYPERNATRAEMIA 70 0.0140
81 STOMA SITE ERYTHEMA 26 0.0139
82 CEREBELLAR HAEMORRHAGE 19 0.0133
83 COGNITIVE DISORDER 613 0.0131
84 LACUNAR INFARCTION 31 0.0129
85 APRAXIA 19 0.0128
86 FAECAL INCONTINENCE 61 0.0127
87 URINARY INCONTINENCE 376 0.0127
88 REHABILITATION THERAPY 49 0.0126
89 MYOCLONUS 150 0.0126
90 PNEUMONIA ASPIRATION 314 0.0126
91 LISTLESS 41 0.0124
92 CONFUSIONAL STATE 1994 0.0123
93 SALIVARY HYPERSECRETION 123 0.0123
94 BEHAVIOUR DISORDER 66 0.0122
95 MIOSIS 96 0.0119
96 HOSPICE CARE 118 0.0119
97 PRESYNCOPE 290 0.0119
98 POTENTIATING DRUG INTERACTION 40 0.0119
99 DUODENAL ULCER HAEMORRHAGE 34 0.0119
100 FAILURE TO THRIVE 60 0.0115
101 ABNORMAL BEHAVIOUR 456 0.0115
102 HAEMORRHAGIC ANAEMIA 50 0.0114
103 UNRESPONSIVE TO STIMULI 292 0.0113
104 HYPERPARATHYROIDISM SECONDARY 28 0.0112
105 ELECTROCARDIOGRAM QT PROLONGED 402 0.0112
106 STARING 27 0.0112
107 FLUID INTAKE REDUCED 55 0.0110
108 SYNCOPE 1095 0.0109
109 FOAMING AT MOUTH 22 0.0109
110 AGGRESSION 544 0.0109
111 HYPOTHERMIA 110 0.0109
112 AGITATION 791 0.0108
113 ON AND OFF PHENOMENON 59 0.0106
114 ATRIOVENTRICULAR BLOCK 82 0.0106
115 DECUBITUS ULCER 86 0.0105
116 PARANOIA 180 0.0104
117 SUPRAVENTRICULAR EXTRASYSTOLES 35 0.0104
118 NEPHROGENIC ANAEMIA 48 0.0104
119 CATATONIA 54 0.0103
120 DIPLOPIA 265 0.0102
121 PHOTOPHOBIA 191 0.0101
122 AKINESIA 21 0.0101
123 DYSKINESIA 410 0.0101
124 MANIA 164 0.0100
125 MUSCLE CONTRACTIONS INVOLUNTARY 35 0.0099
126 MOTOR DYSFUNCTION 99 0.0097
127 HYPERSOMNIA 275 0.0096
128 MENTAL STATUS CHANGES 266 0.0096
129 SUBDURAL HAEMATOMA 137 0.0096
130 HYPOMANIA 35 0.0095
131 ELECTROCARDIOGRAM T WAVE INVERSION 21 0.0095
132 FALL 3158 0.0095
133 INCOHERENT 61 0.0094
134 ASCITES 275 0.0093
135 LOWER GASTROINTESTINAL HAEMORRHAGE 69 0.0093
136 METABOLIC ENCEPHALOPATHY 28 0.0093
137 ASPIRATION 102 0.0093
138 THERAPEUTIC AGENT TOXICITY 31 0.0093
139 IMPAIRED SELF-CARE 19 0.0092
140 HAEMATURIA 314 0.0092
141 SUDDEN DEATH 97 0.0092
142 CARDIO-RESPIRATORY ARREST 382 0.0091
143 DEVICE KINK 33 0.0090
144 GASTRIC ULCER HAEMORRHAGE 50 0.0090
145 AUTONOMIC NERVOUS SYSTEM IMBALANCE 26 0.0089
146 NIGHTMARE 307 0.0089
147 DISORIENTATION 350 0.0088
148 COMA SCALE ABNORMAL 25 0.0086
149 AORTIC STENOSIS 30 0.0086
150 BLOOD CREATINE INCREASED 38 0.0086
151 DUODENAL ULCER 60 0.0085
152 PELVIC FRACTURE 66 0.0085
153 DEPRESSED LEVEL OF CONSCIOUSNESS 335 0.0085
154 BLOOD UREA INCREASED 141 0.0084
155 BEDRIDDEN 109 0.0083
156 ORAL INTAKE REDUCED 20 0.0083
157 COMA 389 0.0082
158 UPPER GASTROINTESTINAL HAEMORRHAGE 136 0.0081
159 BLOOD GLUCOSE FLUCTUATION 88 0.0080
160 PERSECUTORY DELUSION 20 0.0080
161 SCREAMING 51 0.0080
162 CIRCULATORY COLLAPSE 136 0.0080
163 DRUG INTERACTION 1236 0.0078
164 RESTLESSNESS 280 0.0076
165 SEDATION 200 0.0076
166 SLEEP TERROR 32 0.0076
167 HIP FRACTURE 244 0.0076
168 CAROTID ARTERY STENOSIS 26 0.0074
169 CEREBRAL HAEMATOMA 25 0.0074
170 SOCIAL AVOIDANT BEHAVIOUR 43 0.0074
171 BLOOD SODIUM INCREASED 20 0.0074
172 BUNDLE BRANCH BLOCK RIGHT 34 0.0074
173 LETHARGY 425 0.0074
174 LOGORRHOEA 26 0.0074
175 BLINDNESS 299 0.0073
176 CEREBROVASCULAR DISORDER 22 0.0073
177 DIFFICULTY IN WALKING 25 0.0073
178 BALANCE DISORDER 628 0.0073
179 ABNORMAL DREAMS 200 0.0072
180 SPINAL COMPRESSION FRACTURE 59 0.0071
181 EMBOLIC STROKE 25 0.0071
182 DEPRESSIVE SYMPTOM 25 0.0071
183 PARADOXICAL DRUG REACTION 26 0.0071
184 ELECTROENCEPHALOGRAM ABNORMAL 22 0.0070
185 PEPTIC ULCER 23 0.0069
186 HYPERTONIC BLADDER 20 0.0069
187 HEAD INJURY 219 0.0069
188 ANOREXIA 89 0.0069
189 HYPOPHAGIA 176 0.0069
190 MELAENA 151 0.0069
191 LUMBAR SPINAL STENOSIS 20 0.0068
192 SOMNOLENCE 1377 0.0068
193 BUNDLE BRANCH BLOCK LEFT 29 0.0068
194 CEREBRAL INFARCTION 166 0.0068
195 OESOPHAGEAL ULCER 26 0.0068
196 APHASIA 204 0.0067
197 DYSSTASIA 197 0.0067
198 CEREBRAL HAEMORRHAGE 241 0.0067
199 PSYCHOMOTOR HYPERACTIVITY 111 0.0067
200 PEMPHIGOID 50 0.0066
201 URINARY RETENTION 220 0.0066
202 FACE INJURY 25 0.0066
203 ATAXIA 78 0.0066
204 RHABDOMYOLYSIS 274 0.0066
205 HIATUS HERNIA 85 0.0066
206 PERSONALITY CHANGE 60 0.0065
207 DECREASED INTEREST 38 0.0064
208 SUSPECTED SUICIDE 30 0.0064
209 SUBARACHNOID HAEMORRHAGE 65 0.0064
210 APATHY 93 0.0064
211 INITIAL INSOMNIA 65 0.0063
212 COLITIS MICROSCOPIC 30 0.0063
213 WHEELCHAIR USER 28 0.0063
214 PETIT MAL EPILEPSY 32 0.0063
215 FOREIGN BODY 25 0.0062
216 CARDIAC PACEMAKER INSERTION 37 0.0062
217 BENIGN PROSTATIC HYPERPLASIA 32 0.0062
218 DEHYDRATION 826 0.0062
219 CONVULSION 352 0.0061
220 HYPERTONIA 35 0.0061
221 AORTIC VALVE INCOMPETENCE 26 0.0061
222 PROSTATOMEGALY 24 0.0061
223 URINARY TRACT INFECTION 1037 0.0061
224 GRAND MAL CONVULSION 56 0.0061
225 CAROTID ARTERY OCCLUSION 22 0.0060
226 RALES 35 0.0060
227 CYTOLYTIC HEPATITIS 20 0.0060
228 SPEECH DISORDER 314 0.0060
229 HYPOKALAEMIA 275 0.0060
230 ENCEPHALOPATHY 146 0.0059
231 GASTROINTESTINAL HAEMORRHAGE 496 0.0059
232 TINNITUS 272 0.0059
233 EYE PAIN 331 0.0059
234 FRUSTRATION 21 0.0059
235 PSYCHOTIC DISORDER 173 0.0059
236 FAECALOMA 32 0.0058
237 TRANSIENT ISCHAEMIC ATTACK 197 0.0058
238 CEREBRAL ISCHAEMIA 30 0.0058
239 BODY HEIGHT DECREASED 62 0.0058
240 HALLUCINATION, AUDITORY 92 0.0058
241 DIZZINESS POSTURAL 56 0.0058
242 MEMORY IMPAIRMENT 791 0.0058
243 VENTRICULAR TACHYCARDIA 95 0.0057
244 DIVERTICULUM INTESTINAL 25 0.0057
245 HYPOKINESIA 83 0.0057
246 SKIN ABRASION 27 0.0057
247 DYSPHEMIA 25 0.0057
248 HYPONATRAEMIA 317 0.0056
249 AFFECT LABILITY 54 0.0056
250 HICCUPS 46 0.0056
251 HAEMATOMA 145 0.0056
252 TREMOR 926 0.0056
253 PROTEIN TOTAL DECREASED 21 0.0056
254 PRESCRIBED UNDERDOSE 111 0.0056
255 EYE MOVEMENT DISORDER 38 0.0055
256 BRONCHOPNEUMONIA 19 0.0055
257 SKIN LACERATION 60 0.0055
258 CERVICAL VERTEBRAL FRACTURE 19 0.0055
259 HYPOVOLAEMIA 32 0.0055
260 WALKING AID USER 36 0.0055
261 DRUG LEVEL INCREASED 90 0.0054
262 ARTERIOSCLEROSIS CORONARY ARTERY 36 0.0054
263 CARDIAC FAILURE CHRONIC 23 0.0054
264 RIB FRACTURE 111 0.0054
265 GAIT DISTURBANCE 1025 0.0054
266 HEART RATE DECREASED 188 0.0053
267 FRACTURE 101 0.0053
268 RENAL FAILURE CHRONIC 41 0.0053
269 IMPULSIVE BEHAVIOUR 20 0.0053
270 DECREASED APPETITE 1238 0.0053
271 EXTRAPYRAMIDAL DISORDER 132 0.0053
272 POLYDIPSIA 21 0.0053
273 HYPOTONIA 53 0.0053
274 SPINAL COLUMN STENOSIS 25 0.0053
275 LOSS OF CONSCIOUSNESS 671 0.0052
276 AMNESIA 339 0.0052
277 DYSARTHRIA 196 0.0052
278 CARDIOMEGALY 64 0.0052
279 NOCTURIA 63 0.0052
280 MICTURITION URGENCY 59 0.0052
281 HYDROCEPHALUS 28 0.0051
282 DEVICE OCCLUSION 72 0.0051
283 GASTRIC ULCER 97 0.0051
284 LEFT VENTRICULAR DYSFUNCTION 34 0.0051
285 COMPRESSION FRACTURE 27 0.0050
286 DYSPHAGIA 478 0.0050
287 SEPSIS 554 0.0050
288 MOBILITY DECREASED 356 0.0049
289 COLD SWEAT 87 0.0049
290 TERMINAL STATE 33 0.0049
291 ECONOMIC PROBLEM 74 0.0049
292 RENAL FAILURE ACUTE 207 0.0049
293 ABASIA 120 0.0049
294 ABNORMAL LOSS OF WEIGHT 33 0.0048
295 MOVEMENT DISORDER 155 0.0048
296 GAIT INABILITY 161 0.0048
297 ATRIAL FIBRILLATION 469 0.0048
298 LUMBAR VERTEBRAL FRACTURE 22 0.0048
299 HYPERAMMONAEMIA 24 0.0048
300 LACERATION 45 0.0048
301 ARTERIOSCLEROSIS 45 0.0048
302 GENERALISED TONIC-CLONIC SEIZURE 79 0.0048
303 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 49 0.0048
304 INTERNATIONAL NORMALISED RATIO INCREASED 136 0.0048
305 REFUSAL OF TREATMENT BY PATIENT 31 0.0047
306 BLOOD PRESSURE DECREASED 315 0.0047
307 ELECTROCARDIOGRAM ABNORMAL 37 0.0047
308 ILEUS PARALYTIC 21 0.0047
309 HOMICIDAL IDEATION 19 0.0047
310 LEFT VENTRICULAR HYPERTROPHY 20 0.0047
311 IRON DEFICIENCY 21 0.0047
312 UROSEPSIS 43 0.0047
313 MEDICATION ERROR 259 0.0047
314 PERIPHERAL VASCULAR DISORDER 24 0.0047
315 CARDIAC FAILURE ACUTE 31 0.0046
316 TENSION HEADACHE 20 0.0046
317 HUMERUS FRACTURE 22 0.0046
318 EATING DISORDER 97 0.0046
319 SPINAL OSTEOARTHRITIS 40 0.0045
320 EPILEPSY 139 0.0045
321 SHOCK HAEMORRHAGIC 37 0.0045
322 MENTAL IMPAIRMENT 110 0.0045
323 BLOOD ALBUMIN DECREASED 36 0.0045
324 CONCOMITANT DISEASE AGGRAVATED 28 0.0045
325 TRICUSPID VALVE INCOMPETENCE 36 0.0045
326 SEROTONIN SYNDROME 87 0.0045
327 BLOOD MAGNESIUM DECREASED 39 0.0045
328 ANGER 152 0.0045
329 TACHYCARDIA 398 0.0045
330 ESCHERICHIA URINARY TRACT INFECTION 19 0.0045
331 MALNUTRITION 50 0.0045
332 AORTIC ANEURYSM 34 0.0045
333 INFUSION SITE SWELLING 28 0.0044
334 IRON DEFICIENCY ANAEMIA 41 0.0044
335 ACCIDENTAL OVERDOSE 162 0.0044
336 BLOOD PRESSURE FLUCTUATION 105 0.0044
337 DIVERTICULUM 31 0.0044
338 TOXIC ENCEPHALOPATHY 22 0.0043
339 BLOOD POTASSIUM INCREASED 70 0.0043
340 SOMNAMBULISM 28 0.0043
341 COAGULOPATHY 71 0.0043
342 GENERAL PHYSICAL HEALTH DETERIORATION 491 0.0042
343 COORDINATION ABNORMAL 59 0.0042
344 BLADDER DISORDER 42 0.0042
345 HAEMORRHAGE INTRACRANIAL 63 0.0042
346 GRANULOCYTOPENIA 24 0.0042
347 POLLAKIURIA 175 0.0042
348 PROTHROMBIN TIME PROLONGED 25 0.0042
349 HYPOTENSION 836 0.0042
350 HYPERKALAEMIA 146 0.0042
351 LIVER FUNCTION TEST ABNORMAL 120 0.0041
352 ASTHENIA 1551 0.0041
353 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 28 0.0041
354 DECREASED ACTIVITY 44 0.0041
355 ENERGY INCREASED 24 0.0041
356 VENTRICULAR EXTRASYSTOLES 42 0.0040
357 TARDIVE DYSKINESIA 113 0.0040
358 HYPOGLYCAEMIA 194 0.0040
359 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 20 0.0039
360 DYSGRAPHIA 26 0.0039
361 HYPERLIPIDAEMIA 47 0.0039
362 CONTUSION 378 0.0039
363 ANGIOPATHY 22 0.0039
364 SOPOR 52 0.0039
365 CEREBRAL DISORDER 29 0.0039
366 INSOMNIA 1026 0.0038
367 HEPATITIS ACUTE 25 0.0038
368 WRIST FRACTURE 46 0.0038
369 RESPIRATORY RATE INCREASED 34 0.0038
370 PARTIAL SEIZURES 20 0.0038
371 CHOKING 74 0.0038
372 DYSURIA 139 0.0038
373 GASTROENTERITIS 55 0.0038
374 DUODENAL ULCER PERFORATION 28 0.0038
375 FACIAL PARALYSIS 32 0.0038
376 FEEDING DISORDER 76 0.0037
377 GASTRIC HAEMORRHAGE 43 0.0037
378 HYPERHIDROSIS 481 0.0037
379 CORONARY ARTERY DISEASE 113 0.0037
380 DERMATITIS BULLOUS 27 0.0037
381 END STAGE RENAL DISEASE 68 0.0037
382 ATELECTASIS 36 0.0037
383 EXTRASYSTOLES 26 0.0037
384 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 23 0.0037
385 INTENTIONAL UNDERDOSE 27 0.0037
386 ACTIVITIES OF DAILY LIVING IMPAIRED 73 0.0037
387 BLOOD CREATINE PHOSPHOKINASE INCREASED 106 0.0037
388 INFUSION SITE ERYTHEMA 31 0.0037
389 BLOOD PRESSURE INCREASED 562 0.0037
390 DIZZINESS 1833 0.0037
391 INTERVERTEBRAL DISC DEGENERATION 34 0.0037
392 DIABETES MELLITUS INADEQUATE CONTROL 65 0.0037
393 PALLOR 99 0.0036
394 ATRIAL FLUTTER 29 0.0036
395 HAEMATOCRIT DECREASED 72 0.0036
396 POOR QUALITY SLEEP 78 0.0036
397 MITRAL VALVE INCOMPETENCE 41 0.0036
398 DYSTONIA 70 0.0036
399 SPUTUM DISCOLOURED 34 0.0036
400 MAJOR DEPRESSION 26 0.0036
401 CHILLS 417 0.0036
402 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 170 0.0035
403 RENAL CYST 28 0.0035
404 CHRONIC KIDNEY DISEASE 266 0.0035
405 INTERNAL HAEMORRHAGE 40 0.0035
406 THINKING ABNORMAL 65 0.0035
407 PNEUMONIA BACTERIAL 32 0.0035
408 SLEEP DISORDER 246 0.0035
409 CARDIAC FAILURE CONGESTIVE 275 0.0034
410 VENTRICULAR FIBRILLATION 38 0.0034
411 SEIZURE 395 0.0034
412 LIPASE INCREASED 26 0.0034
413 OLIGURIA 21 0.0034
414 ANKLE FRACTURE 52 0.0034
415 FEMUR FRACTURE 104 0.0034
416 PYELONEPHRITIS 29 0.0033
417 MUSCLE TWITCHING 77 0.0033
418 MULTIPLE INJURIES 21 0.0033
419 SLUGGISHNESS 34 0.0033
420 MUSCULAR WEAKNESS 376 0.0033
421 RENAL FAILURE 436 0.0033
422 DEFAECATION URGENCY 23 0.0033
423 HYPERVENTILATION 19 0.0033
424 ELECTROLYTE IMBALANCE 38 0.0033
425 CYSTITIS 104 0.0033
426 BODY TEMPERATURE DECREASED 32 0.0032
427 HEMIPARESIS 55 0.0032
428 CEREBROVASCULAR ACCIDENT 548 0.0032
429 CONCUSSION 25 0.0032
430 SCOLIOSIS 20 0.0032
431 SCRATCH 34 0.0032
432 RECTAL HAEMORRHAGE 138 0.0032
433 URINE OUTPUT DECREASED 28 0.0032
434 FAECES DISCOLOURED 69 0.0032
435 CONDITION AGGRAVATED 959 0.0032
436 ISCHAEMIC STROKE 56 0.0031
437 HEMIPLEGIA 26 0.0031
438 CARDIAC ARREST 258 0.0031
439 HYPOXIA 110 0.0031
440 COMPLETED SUICIDE 260 0.0031
441 ACUTE KIDNEY INJURY 474 0.0031
442 MUSCLE SPASTICITY 38 0.0031
443 SLEEP APNOEA SYNDROME 59 0.0031
444 BLOOD SODIUM DECREASED 58 0.0031
445 ECCHYMOSIS 21 0.0031
446 HYPERGLYCAEMIA 111 0.0030
447 TUBULOINTERSTITIAL NEPHRITIS 57 0.0030
448 CARDIAC FAILURE 244 0.0030
449 BLOOD GLUCOSE ABNORMAL 56 0.0030
450 HEPATIC FUNCTION ABNORMAL 113 0.0030
451 FACIAL PAIN 27 0.0030
452 RESPIRATORY DEPRESSION 37 0.0030
453 ACUTE RESPIRATORY FAILURE 58 0.0030
454 GASTROINTESTINAL INFECTION 27 0.0030
455 CARDIAC MURMUR 26 0.0030
456 PARALYSIS 43 0.0030
457 ERYTHEMA MULTIFORME 28 0.0030
458 CONSTIPATION 654 0.0030
459 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 156 0.0030
460 OEDEMA PERIPHERAL 364 0.0030
461 ACUTE MYOCARDIAL INFARCTION 88 0.0030
462 LEUKOCYTOSIS 54 0.0030
463 DISSEMINATED INTRAVASCULAR COAGULATION 42 0.0030
464 RESTLESS LEGS SYNDROME 54 0.0030
465 GASTRITIS 78 0.0030
466 BLOOD CREATININE INCREASED 191 0.0029
467 ARRHYTHMIA 138 0.0029
468 PRODUCT PRESCRIBING ERROR 69 0.0029
469 ERUCTATION 56 0.0029
470 PRESCRIBED OVERDOSE 56 0.0029
471 CRYING 105 0.0029
472 PNEUMONIA 935 0.0029
473 LARGE INTESTINE POLYP 20 0.0029
474 WEIGHT DECREASED 804 0.0029
475 MENTAL DISORDER 125 0.0029
476 VOMITING 1341 0.0028
477 DEPRESSION 648 0.0028
478 MACULAR DEGENERATION 34 0.0028
479 MIDDLE INSOMNIA 53 0.0028
480 STATUS EPILEPTICUS 32 0.0028
481 RED BLOOD CELL COUNT DECREASED 81 0.0028
482 DIARRHOEA 1823 0.0028
483 WHITE BLOOD CELL COUNT INCREASED 108 0.0028
484 RESPIRATORY FAILURE 205 0.0028
485 IRRITABILITY 169 0.0028
486 RENAL IMPAIRMENT 235 0.0028
487 PETECHIAE 29 0.0028
488 BRAIN OEDEMA 35 0.0028
489 UPPER LIMB FRACTURE 55 0.0028
490 OXYGEN SATURATION DECREASED 155 0.0028
491 CONTRAINDICATED PRODUCT ADMINISTERED 83 0.0027
492 EUPHORIC MOOD 28 0.0027
493 BLOOD POTASSIUM DECREASED 82 0.0027
494 BLOOD PRESSURE DIASTOLIC DECREASED 20 0.0027
495 DERMATITIS ALLERGIC 34 0.0027
496 PRODUCT DISTRIBUTION ISSUE 25 0.0027
497 OSTEOPOROSIS 110 0.0027
498 AFFECTIVE DISORDER 21 0.0027
499 BLOOD CALCIUM DECREASED 30 0.0027
500 BLOOD PRESSURE SYSTOLIC INCREASED 52 0.0027
501 PRODUCT USE COMPLAINT 42 0.0027
502 LIVER FUNCTION TEST INCREASED 57 0.0027
503 DRUG ERUPTION 47 0.0026
504 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
505 NEUTROPHIL COUNT INCREASED 27 0.0026
506 DIVERTICULITIS 73 0.0026
507 THERAPEUTIC RESPONSE UNEXPECTED 118 0.0026
508 ANAEMIA 501 0.0026
509 HYPERTHERMIA 20 0.0026
510 PRODUCT DISPENSING ERROR 57 0.0026
511 DRUG DISPENSING ERROR 40 0.0026
512 CHOLECYSTITIS 31 0.0026
513 CELLULITIS 131 0.0026
514 HYPERCHOLESTEROLAEMIA 25 0.0026
515 RHINORRHOEA 167 0.0026
516 HAEMOGLOBIN DECREASED 265 0.0026
517 ABDOMINAL PAIN UPPER 531 0.0026
518 EMPHYSEMA 26 0.0026
519 DISTURBANCE IN ATTENTION 139 0.0026
520 ROTATOR CUFF SYNDROME 33 0.0026
521 PULMONARY THROMBOSIS 28 0.0026
522 HEART RATE IRREGULAR 58 0.0026
523 VITAMIN D DEFICIENCY 25 0.0026
524 DEAFNESS 67 0.0026
525 SQUAMOUS CELL CARCINOMA 24 0.0025
526 RESPIRATORY ARREST 70 0.0025
527 DEATH 2177 0.0025
528 DRUG-INDUCED LIVER INJURY 79 0.0025
529 HYPERTENSION 533 0.0025
530 LUNG INFILTRATION 22 0.0025
531 FEELING COLD 69 0.0025
532 SHOCK 57 0.0025
533 OESOPHAGITIS 27 0.0025
534 WOUND INFECTION 27 0.0025
535 HAEMATOCHEZIA 136 0.0025
536 TOXICITY TO VARIOUS AGENTS 415 0.0025
537 MYOCARDIAL ISCHAEMIA 28 0.0025
538 COVID-19 PNEUMONIA 29 0.0025
539 PERIPHERAL SWELLING 377 0.0024
540 PANCREATITIS ACUTE 55 0.0024
541 HYPOALBUMINAEMIA 19 0.0024
542 OSTEOPENIA 37 0.0024
543 PLEURAL EFFUSION 148 0.0024
544 TACHYPNOEA 33 0.0024
545 DEPRESSED MOOD 128 0.0024
546 MOOD ALTERED 66 0.0024
547 ACUTE CORONARY SYNDROME 20 0.0024
548 BLOOD PRESSURE ABNORMAL 48 0.0024
549 VISION BLURRED 330 0.0024
550 SUPRAVENTRICULAR TACHYCARDIA 23 0.0024
551 SECRETION DISCHARGE 30 0.0024
552 TREATMENT NONCOMPLIANCE 130 0.0024
553 OSTEOMYELITIS 43 0.0024
554 CARDIOMYOPATHY 35 0.0024
555 JOINT DISLOCATION 25 0.0024
556 MULTIPLE SCLEROSIS RELAPSE 162 0.0024
557 MULTIPLE SCLEROSIS 113 0.0024
558 EYELID PTOSIS 24 0.0024
559 HEPATIC ENCEPHALOPATHY 22 0.0024
560 TYPE 2 DIABETES MELLITUS 79 0.0023
561 KIDNEY INFECTION 46 0.0023
562 JOINT INJURY 50 0.0023
563 VITAMIN D DECREASED 20 0.0023
564 OBSTRUCTIVE AIRWAYS DISORDER 26 0.0023
565 GLAUCOMA 45 0.0023
566 BLOOD ALKALINE PHOSPHATASE INCREASED 58 0.0023
567 PERIPHERAL COLDNESS 32 0.0023
568 WOUND 65 0.0023
569 EYELID OEDEMA 27 0.0023
570 PROSTATIC SPECIFIC ANTIGEN INCREASED 32 0.0023
571 HAEMORRHOIDS 45 0.0023
572 FATIGUE 1796 0.0023
573 ABDOMINAL PAIN 535 0.0023
574 NO THERAPEUTIC RESPONSE 28 0.0023
575 STEVENS-JOHNSON SYNDROME 51 0.0023
576 OEDEMA 124 0.0023
577 INCREASED TENDENCY TO BRUISE 21 0.0023
578 MALAISE 1001 0.0023
579 HYPOACUSIS 98 0.0023
580 COUGH 637 0.0023
581 PRODUCTIVE COUGH 108 0.0023
582 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20 0.0023
583 CHROMATURIA 51 0.0023
584 CHOLELITHIASIS 74 0.0023
585 MULTI-ORGAN FAILURE 39 0.0023
586 ILEUS 28 0.0023
587 RETCHING 48 0.0022
588 SPINAL FRACTURE 45 0.0022
589 MUSCLE SPASMS 412 0.0022
590 INABILITY TO AFFORD MEDICATION 22 0.0022
591 BLOOD URINE PRESENT 42 0.0022
592 MUSCLE ATROPHY 28 0.0022
593 LIVER DISORDER 98 0.0022
594 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
595 FACE OEDEMA 37 0.0022
596 SCAB 25 0.0022
597 MUSCULOSKELETAL STIFFNESS 192 0.0022
598 INFUSION SITE PAIN 28 0.0022
599 PYREXIA 750 0.0022
600 FOOT DEFORMITY 24 0.0022
601 UNDERDOSE 158 0.0022
602 DEVICE DISLOCATION 94 0.0022
603 NAUSEA 1708 0.0022
604 LYMPHOCYTE COUNT DECREASED 38 0.0021
605 MYALGIA 365 0.0021
606 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
607 RESPIRATORY DISTRESS 59 0.0021
608 MUSCULOSKELETAL CHEST PAIN 33 0.0021
609 HYPOTHYROIDISM 68 0.0021
610 AKATHISIA 29 0.0021
611 ANXIETY 604 0.0021
612 BACK INJURY 23 0.0021
613 PRODUCT DOSE OMISSION 138 0.0021
614 PRODUCT DOSE OMISSION ISSUE 620 0.0021
615 RESPIRATORY DISORDER 63 0.0021
616 TRANSFUSION 22 0.0021
617 FEELING JITTERY 40 0.0021
618 BRAIN INJURY 21 0.0021
619 ASPARTATE AMINOTRANSFERASE INCREASED 111 0.0021
620 C-REACTIVE PROTEIN INCREASED 76 0.0021
621 RENAL INJURY 62 0.0021
622 NERVOUSNESS 109 0.0021
623 VERTIGO 127 0.0021
624 PRODUCT DOSE OMISSION IN ERROR 59 0.0021
625 FEAR 56 0.0021
626 THERAPEUTIC RESPONSE SHORTENED 69 0.0021
627 PULMONARY OEDEMA 92 0.0021
628 SPLENOMEGALY 24 0.0020
629 INCREASED APPETITE 39 0.0020
630 RENAL DISORDER 95 0.0020
631 THERAPY CHANGE 20 0.0020
632 SPINAL OPERATION 25 0.0020
633 BIPOLAR DISORDER 22 0.0020
634 DYSPNOEA EXERTIONAL 76 0.0020
635 PULMONARY HYPERTENSION 42 0.0020
636 ADVERSE DRUG REACTION 181 0.0020
637 DYSPNOEA 1138 0.0020
638 OSTEOARTHRITIS 85 0.0020
639 BLOOD BILIRUBIN INCREASED 54 0.0020
640 NEUROTOXICITY 35 0.0020
641 HYPERTENSIVE CRISIS 22 0.0020
642 INFUSION RELATED REACTION 131 0.0020
643 ABDOMINAL DISCOMFORT 331 0.0020
644 BRONCHITIS 146 0.0020
645 ALANINE AMINOTRANSFERASE INCREASED 121 0.0020
646 METABOLIC ACIDOSIS 63 0.0020
647 BACK DISORDER 32 0.0020
648 INTENTIONAL DOSE OMISSION 56 0.0020
649 DRUG ADMINISTRATION ERROR 60 0.0020
650 LIMB INJURY 53 0.0019
651 HYPERCALCAEMIA 24 0.0019
652 OSTEONECROSIS OF JAW 48 0.0019
653 HYPOMAGNESAEMIA 27 0.0019
654 HEPATOMEGALY 19 0.0019
655 SKIN LESION 53 0.0019
656 GASTROINTESTINAL DISORDER 173 0.0019
657 DERMATITIS CONTACT 22 0.0019
658 BACK PAIN 447 0.0019
659 CHEST PAIN 356 0.0019
660 HEPATIC CIRRHOSIS 36 0.0019
661 MULTIPLE ORGAN DYSFUNCTION SYNDROME 54 0.0019
662 CATARACT 113 0.0019
663 MUSCULOSKELETAL DISORDER 36 0.0019
664 VASCULITIS 22 0.0019
665 STAPHYLOCOCCAL INFECTION 62 0.0019
666 HEPATITIS 48 0.0019
667 FEELING ABNORMAL 447 0.0019
668 ANOSMIA 27 0.0019
669 BODY TEMPERATURE INCREASED 38 0.0019
670 ILL-DEFINED DISORDER 113 0.0019
671 SKIN CANCER 40 0.0019
672 BLOOD IRON DECREASED 22 0.0019
673 BRAIN FOG 29 0.0018
674 DYSPHONIA 108 0.0018
675 CYANOSIS 29 0.0018
676 GASTROOESOPHAGEAL REFLUX DISEASE 148 0.0018
677 PRODUCT PRESCRIBING ISSUE 40 0.0018
678 ANHEDONIA 48 0.0018
679 CORONARY ARTERY OCCLUSION 25 0.0018
680 HOSPITALISATION 280 0.0018
681 PLATELET COUNT DECREASED 194 0.0018
682 THYROID DISORDER 28 0.0018
683 PULMONARY MASS 27 0.0018
684 CARDIOVASCULAR DISORDER 46 0.0018
685 THERAPY CESSATION 93 0.0018
686 UNEVALUABLE EVENT 137 0.0018
687 GAMMA-GLUTAMYLTRANSFERASE INCREASED 40 0.0018
688 FULL BLOOD COUNT ABNORMAL 19 0.0018
689 MYDRIASIS 23 0.0018
690 MOOD SWINGS 57 0.0018
691 SMALL INTESTINAL OBSTRUCTION 22 0.0018
692 CLOSTRIDIUM DIFFICILE INFECTION 39 0.0018
693 DEEP VEIN THROMBOSIS 116 0.0018
694 PRODUCT ADMINISTRATION ERROR 36 0.0018
695 CONJUNCTIVITIS 33 0.0018
696 CARDIAC DISORDER 166 0.0018
697 SEASONAL ALLERGY 25 0.0018
698 DIALYSIS 25 0.0018
699 IMPAIRED DRIVING ABILITY 20 0.0018
700 ACUTE HEPATIC FAILURE 24 0.0018
701 PANIC ATTACK 64 0.0018
702 INTERSTITIAL LUNG DISEASE 85 0.0018
703 CENTRAL NERVOUS SYSTEM LESION 24 0.0017
704 DIABETES MELLITUS 133 0.0017
705 CARDIOGENIC SHOCK 25 0.0017
706 NIGHT SWEATS 56 0.0017
707 WHEEZING 103 0.0017
708 SUICIDAL IDEATION 159 0.0017
709 HEADACHE 1088 0.0017
710 MUSCLE TIGHTNESS 28 0.0017
711 MYOCARDIAL INFARCTION 300 0.0017
712 EMOTIONAL DISORDER 53 0.0017
713 THROMBOSIS 138 0.0017
714 DEVICE USE ISSUE 30 0.0017
715 BLOOD COUNT ABNORMAL 26 0.0017
716 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
717 JAUNDICE 46 0.0017
718 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 29 0.0017
719 FREQUENT BOWEL MOVEMENTS 46 0.0017
720 OVERDOSE 367 0.0017
721 NEPHROLITHIASIS 78 0.0017
722 OBESITY 27 0.0017
723 FLATULENCE 96 0.0017
724 PLATELET COUNT INCREASED 22 0.0017
725 TOOTH EXTRACTION 21 0.0017
726 FULL BLOOD COUNT DECREASED 34 0.0017
727 IMPAIRED GASTRIC EMPTYING 23 0.0017
728 EPISTAXIS 126 0.0017
729 SWELLING FACE 109 0.0017
730 WHITE BLOOD CELL COUNT DECREASED 181 0.0017
731 IMPAIRED QUALITY OF LIFE 24 0.0017
732 LACTIC ACIDOSIS 54 0.0017
733 DRY MOUTH 135 0.0017
734 SKIN ULCER 43 0.0017
735 LOCAL SWELLING 29 0.0017
736 INCORRECT PRODUCT ADMINISTRATION DURATION 36 0.0017
737 DISEASE RECURRENCE 79 0.0017
738 HYPERTHYROIDISM 24 0.0017
739 LOCALISED INFECTION 40 0.0017
740 COVID-19 288 0.0016
741 GASTRIC DISORDER 56 0.0016
742 DEVICE ISSUE 146 0.0016
743 LABORATORY TEST ABNORMAL 48 0.0016
744 GLYCOSYLATED HAEMOGLOBIN INCREASED 41 0.0016
745 WRONG TECHNIQUE IN DRUG USAGE PROCESS 59 0.0016
746 DRUG EFFECT LESS THAN EXPECTED 24 0.0016
747 SKIN HAEMORRHAGE 24 0.0016
748 PULMONARY FIBROSIS 31 0.0016
749 DRUG TOXICITY 22 0.0016
750 AGRANULOCYTOSIS 30 0.0016
751 LOWER LIMB FRACTURE 31 0.0016
752 PANCYTOPENIA 90 0.0016
753 NECK PAIN 90 0.0016
754 ROAD TRAFFIC ACCIDENT 67 0.0016
755 ORAL CANDIDIASIS 21 0.0016
756 INJURY 112 0.0016
757 SARS-COV-2 TEST POSITIVE 21 0.0016
758 HYPOCALCAEMIA 30 0.0016
759 BLOOD TRIGLYCERIDES INCREASED 28 0.0016
760 THERAPY INTERRUPTED 113 0.0016
761 PULMONARY EMBOLISM 150 0.0016
762 EYE HAEMORRHAGE 21 0.0016
763 RASH MACULO-PAPULAR 35 0.0016
764 CARPAL TUNNEL SYNDROME 22 0.0016
765 MUSCULOSKELETAL DISCOMFORT 27 0.0016
766 BLOOD TEST ABNORMAL 22 0.0016
767 LEUKOPENIA 78 0.0016
768 PRURITUS 599 0.0016
769 FEELING HOT 95 0.0015
770 LUNG INFECTION 24 0.0015
771 EJECTION FRACTION DECREASED 24 0.0015
772 BRONCHOSPASM 22 0.0015
773 BASAL CELL CARCINOMA 24 0.0015
774 RESPIRATORY TRACT INFECTION 40 0.0015
775 ANGINA PECTORIS 44 0.0015
776 FOOT FRACTURE 29 0.0015
777 ARTHRALGIA 635 0.0015
778 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 108 0.0015
779 PULMONARY CONGESTION 20 0.0015
780 COMPLICATION ASSOCIATED WITH DEVICE 22 0.0015
781 PNEUMOTHORAX 24 0.0015
782 DRUG PRESCRIBING ERROR 29 0.0015
783 HIP ARTHROPLASTY 23 0.0015
784 PERITONITIS 31 0.0015
785 FLUID RETENTION 76 0.0015
786 HAEMORRHAGE 156 0.0015
787 QUALITY OF LIFE DECREASED 20 0.0015
788 LIMB DISCOMFORT 46 0.0015
789 SINUS TACHYCARDIA 21 0.0015
790 BLISTER 83 0.0015
791 COLON CANCER 22 0.0015
792 BLOOD GLUCOSE INCREASED 278 0.0015
793 ORAL PAIN 33 0.0015
794 KNEE ARTHROPLASTY 31 0.0015
795 LIP SWELLING 49 0.0015
796 RASH MACULAR 51 0.0015
797 DISCOMFORT 89 0.0015
798 INCORRECT DRUG ADMINISTRATION DURATION 41 0.0015
799 MYELODYSPLASTIC SYNDROME 21 0.0015
800 COLITIS 55 0.0014
801 AGEUSIA 36 0.0014
802 SCIATICA 23 0.0014
803 RASH PRURITIC 78 0.0014
804 VISUAL IMPAIRMENT 178 0.0014
805 WITHDRAWAL SYNDROME 60 0.0014
806 RASH PAPULAR 32 0.0014
807 ABDOMINAL DISTENSION 149 0.0014
808 PHARMACEUTICAL PRODUCT COMPLAINT 37 0.0014
809 ABDOMINAL PAIN LOWER 36 0.0014
810 SUICIDE ATTEMPT 86 0.0014
811 MALIGNANT MELANOMA 19 0.0014
812 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
813 SKIN DISCOLOURATION 65 0.0014
814 APPLICATION SITE PRURITUS 32 0.0014
815 ILLNESS 145 0.0014
816 PANCREATITIS 74 0.0014
817 BLOOD GLUCOSE DECREASED 67 0.0014
818 DISEASE PROGRESSION 165 0.0014
819 GOUT 25 0.0014
820 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 99 0.0014
821 LUNG DISORDER 68 0.0014
822 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 76 0.0014
823 GASTROENTERITIS VIRAL 25 0.0014
824 PERICARDIAL EFFUSION 32 0.0014
825 INSURANCE ISSUE 21 0.0014
826 BONE DISORDER 25 0.0014
827 INTENTIONAL OVERDOSE 88 0.0014
828 HOT FLUSH 103 0.0014
829 UPPER RESPIRATORY TRACT INFECTION 63 0.0014
830 LUNG NEOPLASM MALIGNANT 56 0.0014
831 ARTHRITIS 107 0.0014
832 LYMPHOMA 21 0.0014
833 LACRIMATION INCREASED 41 0.0014
834 SEPTIC SHOCK 59 0.0014
835 DRUG DOSE OMISSION 224 0.0014
836 VIRAL INFECTION 45 0.0014
837 LYMPHOPENIA 19 0.0013
838 THIRST 24 0.0013
839 APPLICATION SITE ERYTHEMA 35 0.0013
840 THROMBOCYTOPENIA 149 0.0013
841 HAEMOPTYSIS 37 0.0013
842 DRUG INTOLERANCE 128 0.0013
843 VISUAL ACUITY REDUCED 44 0.0013
844 RASH GENERALISED 34 0.0013
845 PRURITUS GENERALISED 28 0.0013
846 HERNIA 25 0.0013
847 INFLUENZA 144 0.0013
848 DIABETIC KETOACIDOSIS 31 0.0013
849 PRODUCT USE ISSUE 242 0.0013
850 BACTERIAL INFECTION 24 0.0013
851 OFF LABEL USE 1125 0.0013
852 DYSPEPSIA 126 0.0013
853 NEUROPATHY PERIPHERAL 121 0.0013
854 HERPES ZOSTER 73 0.0013
855 BLOOD CHOLESTEROL INCREASED 59 0.0013
856 PAIN IN EXTREMITY 372 0.0013
857 MUSCULOSKELETAL PAIN 66 0.0013
858 ULCER 20 0.0013
859 PLASMA CELL MYELOMA 49 0.0013
860 HEART RATE INCREASED 124 0.0013
861 PERICARDITIS 21 0.0012
862 CHOLESTASIS 24 0.0012
863 DRUG INEFFECTIVE 1647 0.0012
864 DEVICE FAILURE 19 0.0012
865 EYE DISORDER 41 0.0012
866 SENSORY DISTURBANCE 20 0.0012
867 INTENTIONAL DRUG MISUSE 26 0.0012
868 FLUSHING 126 0.0012
869 GALLBLADDER DISORDER 22 0.0012
870 SURGERY 72 0.0012
871 PRODUCT USE IN UNAPPROVED INDICATION 304 0.0012
872 DRUG EFFECT DECREASED 66 0.0012
873 LIVER INJURY 30 0.0012
874 ANGIOEDEMA 54 0.0012
875 DRUG RESISTANCE 31 0.0012
876 THERAPEUTIC PRODUCT EFFECT DECREASED 54 0.0012
877 FUNGAL INFECTION 40 0.0012
878 PALPITATIONS 139 0.0012
879 CHEST DISCOMFORT 121 0.0012
880 OCULAR HYPERAEMIA 56 0.0012
881 NERVOUS SYSTEM DISORDER 36 0.0012
882 HYPOAESTHESIA 172 0.0011
883 POST PROCEDURAL COMPLICATION 22 0.0011
884 EOSINOPHILIA 20 0.0011
885 PNEUMONITIS 31 0.0011
886 EAR PAIN 22 0.0011
887 EYE PRURITUS 38 0.0011
888 DRUG EFFECT INCOMPLETE 41 0.0011
889 HEPATIC STEATOSIS 21 0.0011
890 JOINT SWELLING 136 0.0011
891 RASH 491 0.0011
892 INFECTION 163 0.0011
893 INTENTIONAL PRODUCT MISUSE 98 0.0011
894 INFLUENZA LIKE ILLNESS 92 0.0011
895 EYE IRRITATION 64 0.0011
896 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
897 PAIN 679 0.0011
898 WEIGHT INCREASED 247 0.0011
899 NASOPHARYNGITIS 203 0.0011
900 INCORRECT DOSE ADMINISTERED 250 0.0011
901 THERAPY NON-RESPONDER 49 0.0011
902 SWOLLEN TONGUE 34 0.0011
903 INTESTINAL OBSTRUCTION 41 0.0011
904 SKIN DISORDER 36 0.0011
905 ASTHMA 121 0.0011
906 EXTRA DOSE ADMINISTERED 43 0.0011
907 TOOTH LOSS 22 0.0011
908 MIGRAINE 100 0.0010
909 PAIN OF SKIN 28 0.0010
910 TASTE DISORDER 21 0.0010
911 TRANSAMINASES INCREASED 23 0.0010
912 LOWER RESPIRATORY TRACT INFECTION 47 0.0010
913 ADVERSE EVENT 95 0.0010
914 PARAESTHESIA 162 0.0010
915 HEPATIC FAILURE 31 0.0010
916 NEURALGIA 25 0.0010
917 INFLAMMATION 53 0.0010
918 BURNING SENSATION 72 0.0010
919 GASTRIC CANCER 26 0.0010
920 SWELLING 96 0.0010
921 EYE SWELLING 38 0.0010
922 SINUSITIS 104 0.0010
923 HEPATIC ENZYME INCREASED 69 0.0010
924 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 182 0.0010
925 DRY EYE 50 0.0010
926 EXPIRED PRODUCT ADMINISTERED 33 0.0010
927 PRODUCT PHYSICAL ISSUE 20 0.0010
928 LYMPHADENOPATHY 35 0.0010
929 OSTEONECROSIS 32 0.0010
930 PRODUCT AVAILABILITY ISSUE 22 0.0010
931 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 195 0.0010
932 ERYTHEMA 192 0.0009
933 THERAPEUTIC RESPONSE DECREASED 56 0.0009
934 BONE PAIN 54 0.0009
935 RASH ERYTHEMATOUS 44 0.0009
936 ALOPECIA 177 0.0009
937 ARTHROPATHY 50 0.0009
938 HEPATOTOXICITY 20 0.0009
939 NEOPLASM MALIGNANT 58 0.0009
940 PRODUCT SUBSTITUTION ISSUE 50 0.0009
941 NEUTROPENIA 118 0.0009
942 PANCREATIC CARCINOMA 25 0.0009
943 SKIN EXFOLIATION 73 0.0009
944 DRUG ABUSE 72 0.0009
945 THROAT IRRITATION 38 0.0008
946 FIBROMYALGIA 20 0.0008
947 INTENTIONAL PRODUCT USE ISSUE 72 0.0008
948 OROPHARYNGEAL PAIN 76 0.0008
949 NASAL CONGESTION 48 0.0008
950 ANAPHYLACTIC SHOCK 21 0.0008
951 THROAT TIGHTNESS 22 0.0008
952 EMOTIONAL DISTRESS 98 0.0008
953 IMPAIRED HEALING 26 0.0008
954 DEVICE BREAKAGE 32 0.0008
955 ECZEMA 41 0.0008
956 JOINT STIFFNESS 20 0.0008
957 DEVICE LEAKAGE 33 0.0008
958 NEUTROPHIL COUNT DECREASED 31 0.0008
959 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 22 0.0008
960 PAIN IN JAW 21 0.0007
961 DYSGEUSIA 55 0.0007
962 INCORRECT ROUTE OF DRUG ADMINISTRATION 25 0.0007
963 DRUG WITHDRAWAL SYNDROME 61 0.0007
964 DRY SKIN 91 0.0007
965 BONE DENSITY DECREASED 21 0.0007
966 DEVICE USE ERROR 22 0.0006
967 NEOPLASM PROGRESSION 22 0.0006
968 URTICARIA 103 0.0006
969 PRODUCT QUALITY ISSUE 83 0.0006
970 MALIGNANT NEOPLASM PROGRESSION 61 0.0006
971 HYPERSENSITIVITY 110 0.0006
972 TREATMENT FAILURE 47 0.0006
973 SYSTEMIC LUPUS ERYTHEMATOSUS 20 0.0006
974 PROSTATE CANCER 44 0.0005
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 24 0.0005
976 NO ADVERSE EVENT 93 0.0005
977 FEBRILE NEUTROPENIA 34 0.0005
978 STOMATITIS 31 0.0005
979 BREAST CANCER 46 0.0005
980 INJECTION SITE BRUISING 38 0.0005
981 RHEUMATOID ARTHRITIS 54 0.0005
982 ACCIDENTAL EXPOSURE TO PRODUCT 49 0.0005
983 ANAPHYLACTIC REACTION 25 0.0005
984 DEVICE MALFUNCTION 30 0.0004
985 DEVICE DIFFICULT TO USE 27 0.0004
986 INJECTION SITE HAEMORRHAGE 31 0.0004
987 INJECTION SITE ERYTHEMA 48 0.0004
988 DRUG DEPENDENCE 62 0.0004
989 INJECTION SITE PAIN 103 0.0003
990 PRODUCT STORAGE ERROR 29 0.0003
991 PSORIASIS 39 0.0003
992 INJECTION SITE SWELLING 21 0.0003